Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
4.110
+0.170 (4.31%)
Oct 20, 2026, 11:15 AM EDT - Market open
Taysha Gene Therapies Market Cap
Taysha Gene Therapies has a market cap or net worth of $1.34 billion as of October 20, 2026. It is the 8,801st most valuable company in the world and the 2,061st biggest in the United States. Its market cap has increased by 4.01% in one year.
Market Cap
1.34B
Enterprise Value
940.48M
1-Year Change
4.01%
Global Rank
Country Rank
#2,061 United States
Category
ChartMarket Cap Chart
Since the IPO on September 24, 2020, Taysha Gene Therapies's market cap has increased from $690.43M to $1.34B, an increase of 93.96%. That is a compound annual growth rate of 11.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2026 | 1.34B | -11.11% |
| Dec 31, 2025 | 1.51B | 324.92% |
| Dec 31, 2024 | 354.55M | 7.14% |
| Dec 29, 2023 | 330.92M | 134.50% |
| Dec 30, 2022 | 141.12M | -68.52% |
| Dec 31, 2021 | 448.22M | -55.28% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 24, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GH Research | 1.25B |
| First Tracks Biotherapeutics | 1.23B |
| Nektar Therapeutics | 1.22B |
| Kardigan | 1.22B |
| LB Pharmaceuticals | 1.19B |
| Omeros | 1.17B |
| Syndax Pharmaceuticals | 1.15B |
| Damora Therapeutics | 1.14B |